Metraipolis › archive › dc_e5e0b526fa17
Toward Personalized ACS Therapy: How Disease Status and Patient Lifestyle Shape the Molecular Signature of Autologous Conditioned Serum — Europe PMC PMID:41682693
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41682693
- DOI
- 10.3390/jcm15031014
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T12:08:22.199Z
- SHA-256 of the archived text
57c9707083354f8d959655c53069983e67d13b0adf9fa964939c362763ab0c92- Stable URL of this page
https://metraipolis.com/documento/dc_e5e0b526fa17
How to cite
Toward Personalized ACS Therapy: How Disease Status and Patient Lifestyle Shape the Molecular Signature of Autologous Conditioned Serum — Europe PMC PMID:41682693 — Europe PMC (en), https://europepmc.org/article/MED/41682693 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e5e0b526fa17 (Metraipolis archive dc_e5e0b526fa17, sha256 57c9707083354f8d959655c53069983e67d13b0adf9fa964939c362763ab0c92)
BibTeX
@misc{dce5e0b526fa17,
title = {Toward Personalized ACS Therapy: How Disease Status and Patient Lifestyle Shape the Molecular Signature of Autologous Conditioned Serum — Europe PMC PMID:41682693},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41682693},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e5e0b526fa17; sha256 57c9707083354f8d959655c53069983e67d13b0adf9fa964939c362763ab0c92},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41682693. Agents can read the archived copy with the MCP tool read_document.